Found: 23
Select item for more details and to access through your institution.
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1191217
- By:
- Publication type:
- Article
The NF1 +/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 994, doi. 10.3390/cancers16050994
- By:
- Publication type:
- Article
Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
- Published in:
- Clinical Trials, 2024, v. 21, n. 1, p. 40, doi. 10.1177/17407745231203330
- By:
- Publication type:
- Article
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 5, p. 531, doi. 10.1007/s11912-023-01388-3
- By:
- Publication type:
- Article
Correction: Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cells.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 4, p. 860, doi. 10.1002/1878-0261.13027
- By:
- Publication type:
- Article
Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Brain Death Secondary to Rocky Mountain Spotted Fever Encephalitis.
- Published in:
- Case Reports in Critical Care, 2020, p. 1, doi. 10.1155/2020/5329420
- By:
- Publication type:
- Article
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 16, p. 2752, doi. 10.1093/hmg/ddz095
- By:
- Publication type:
- Article
proteasome-resistant fragment of NIK mediates oncogenic NF- κ B signaling in schwannomas.
- Published in:
- Human Molecular Genetics, 2019, v. 28, n. 4, p. 572, doi. 10.1093/hmg/ddy361
- By:
- Publication type:
- Article
Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.
- Published in:
- Journal of Bone & Mineral Research, 2015, v. 30, n. 10, p. 1840, doi. 10.1002/jbmr.2538
- By:
- Publication type:
- Article
Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 6, p. 12345, doi. 10.3390/ijms160612345
- By:
- Publication type:
- Article
Dystrophic Spinal Deformities in a Neurofibromatosis Type 1 Murine Model.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0119093
- By:
- Publication type:
- Article
A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 1, p. 1, doi. 10.1093/hmg/ddu414
- By:
- Publication type:
- Article
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
- Published in:
- Human Molecular Genetics, 2013, v. 22, n. 23, p. 4818, doi. 10.1093/hmg/ddt333
- By:
- Publication type:
- Article
Hyperactive Transforming Growth Factor-β1 Signaling Potentiates Skeletal Defects in a Neurofibromatosis Type 1 Mouse Model.
- Published in:
- Journal of Bone & Mineral Research, 2013, v. 28, n. 12, p. 2476, doi. 10.1002/jbmr.1992
- By:
- Publication type:
- Article
Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 1, p. 329, doi. 10.1172/JCI66167
- By:
- Publication type:
- Article
c-Fms Signaling Mediates Neurofibromatosis Type-1 Osteoclast Gain-In-Functions.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0046900
- By:
- Publication type:
- Article
The Haploinsufficient Hematopoietic Microenvironment Is Critical to the Pathological Fracture Repair in Murine Models of Neurofibromatosis Type 1.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024917
- By:
- Publication type:
- Article
Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0024780
- By:
- Publication type:
- Article
Reconstitution of Human Peripheral Cannabinoid Receptor CB2 into Phosphatidylcholine Proteoliposomes.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A983
- By:
- Publication type:
- Article